Seven Grand Managers LLC Purchases Shares of 250,000 Sotera Health Company $SHC

Seven Grand Managers LLC purchased a new stake in Sotera Health Company (NASDAQ:SHC) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 250,000 shares of the company’s stock, valued at approximately $4,410,000. Seven Grand Managers LLC owned 0.09% of Sotera Health at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in the company. Geode Capital Management LLC increased its stake in shares of Sotera Health by 13.8% in the fourth quarter. Geode Capital Management LLC now owns 3,931,834 shares of the company’s stock valued at $69,372,000 after purchasing an additional 476,365 shares during the period. Legal & General Group Plc increased its stake in shares of Sotera Health by 20.7% in the fourth quarter. Legal & General Group Plc now owns 308,389 shares of the company’s stock valued at $5,440,000 after purchasing an additional 52,863 shares during the period. EverSource Wealth Advisors LLC increased its stake in shares of Sotera Health by 114.3% in the fourth quarter. EverSource Wealth Advisors LLC now owns 7,572 shares of the company’s stock valued at $134,000 after purchasing an additional 4,038 shares during the period. IFP Advisors Inc increased its stake in shares of Sotera Health by 1,105.6% in the fourth quarter. IFP Advisors Inc now owns 1,495 shares of the company’s stock valued at $26,000 after purchasing an additional 1,371 shares during the period. Finally, PNC Financial Services Group Inc. increased its stake in shares of Sotera Health by 10.8% in the fourth quarter. PNC Financial Services Group Inc. now owns 7,204 shares of the company’s stock valued at $127,000 after purchasing an additional 705 shares during the period. Institutional investors and hedge funds own 91.03% of the company’s stock.

Sotera Health Price Performance

NASDAQ SHC opened at $15.54 on Thursday. Sotera Health Company has a 12 month low of $10.80 and a 12 month high of $19.85. The company has a debt-to-equity ratio of 3.56, a current ratio of 2.82 and a quick ratio of 2.54. The firm has a market capitalization of $4.43 billion, a PE ratio of 37.90 and a beta of 1.82. The company’s 50 day simple moving average is $15.12 and its 200 day simple moving average is $16.38.

Sotera Health (NASDAQ:SHC) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $0.18 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.01. The firm had revenue of $280.05 million for the quarter, compared to analyst estimates of $270.78 million. Sotera Health had a net margin of 9.91% and a return on equity of 39.73%. The firm’s quarterly revenue was up 10.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.14 earnings per share. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. As a group, equities research analysts forecast that Sotera Health Company will post 0.86 EPS for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts have commented on the stock. Piper Sandler restated an “overweight” rating and issued a $22.00 price target (down from $24.00) on shares of Sotera Health in a research note on Wednesday, May 6th. Barclays lowered their price objective on shares of Sotera Health from $20.00 to $18.00 and set an “overweight” rating on the stock in a research note on Tuesday, April 14th. Zacks Research lowered shares of Sotera Health from a “strong-buy” rating to a “hold” rating in a research note on Friday, January 30th. Weiss Ratings lowered shares of Sotera Health from a “hold (c)” rating to a “hold (c-)” rating in a research note on Thursday, May 21st. Finally, Citigroup raised their price objective on shares of Sotera Health from $21.00 to $23.00 and gave the company a “buy” rating in a research note on Tuesday, February 24th. Seven investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $20.33.

Insider Transactions at Sotera Health

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of Sotera Health stock in a transaction that occurred on Wednesday, May 13th. The shares were sold at an average price of $15.17, for a total value of $193,194,516.17. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 15.36% of the company’s stock.

Sotera Health Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.